Talphera's Chief Medical Officer Increases Investment in Company Shares Aslam Shakil, Talphera's Chief Medical Officer, recently acquired 5,695 company shares for $6,038, signaling confidence in the firm's future. Despite a 12% stock drop last week, this insider purchase raises Shakil's ownership to 37,695 shares. Talphera also faces Nasdaq compliance challenges but remains focused on advancing its clinical trials.1